Business
Q1 Earning Preview: Is Alphabet Overspending? A Painful Lesson From Meta And Intel (GOOG)
Summit Research focused on finding fundamental- and catalyst-driven long/short ideas in the tech sector. Key industries covered include big tech, electric vehicles and autonomous mobility, semiconductors, software, and AI.
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Business
4 ways to shore up South Asian coastal communities against climate change
Marginalized South Asian communities, particularly coastal dwellers in Pakistan, the Maldives, and Bangladesh’s GBM delta, face critical climate change risks. Rising sea levels and extreme weather events like Pakistan’s monsoon floods threaten livelihoods and homes, forcing displacement and profession changes.
Key Challenges
- High vulnerability: Coastal communities in Pakistan, Bangladesh, and the Maldives face severe risks from flooding and rising sea levels.
- Pakistan: Monster monsoons and rising seas have displaced millions, forcing farmers to switch to fishing.
- Bangladesh: The Ganges-Brahmaputra-Meghna delta and Sundarbans mangrove forest are under threat, with Dhaka absorbing thousands of climate refugees daily.
- Maldives: Rising seas could make the island nation disappear by 2100.
South Asian coastal communities are disappearing at alarming rates due to climate change. Solutions require a mix of nature-based restoration, resilient infrastructure, planned relocation, and innovative engineering to safeguard livelihoods and cultures.
The Maldives, an archipelago nation, is at risk of disappearing entirely. Solutions include mangrove restoration for coastal protection, building raised homes to mitigate floods, relocating communities to climate-resilient cities, and constructing artificial islands like Hulhumalé in the Maldives. These adaptations are vital to protect vulnerable populations from an existential threat.
Other People are Reading
Business
Justice Department drops criminal probe of Fed chair Powell, likely clearing way for Warsh
U.S. Attorney for the District of Columbia Jeannine Pirro said on X on Friday that her office was ending its probe into the Fed’s extensive building renovations because the Fed’s inspector general would scrutinize them instead.
The move could lead to a swift confirmation vote by the Senate for Warsh, a former top Fed official whom President Donald Trump, a Republican, nominated in January to replace Powell. Powell’s term as chair ends May 15. Sen. Thom Tillis, a North Carolina Republican, had said he would oppose Warsh until the investigation was resolved, effectively blocking his confirmation.
With the investigation completed, the leadership transition at the world’s leading central bank may proceed quickly. Republicans praised Warsh during a Tuesday hearing even as Democrats questioned his independence from Trump, the lack of transparency around some of his financial holdings, and what they said was his flip-flopping on interest rates. Still, Trump’s previous appointment to the Fed’s board of governors, Stephen Miran, was approved by the full Senate just 13 days after his nomination.
The investigation was among several undertaken by the Justice Department into Trump’s perceived adversaries. For months it had failed to gain traction as prosecutors struggled to articulate a basis to suspect criminal conduct.
A prosecutor handling the case conceded at a closed-door court hearing in March that the government hadn’t yet found any evidence of a crime, and a judge subsequently quashed subpoenas issued to the Federal Reserve. The judge, James Boasberg, said prosecutors had produced “essentially zero evidence” to suspect Powell of a crime. Boasberg branded prosecutors’ justification for the subpoenas as “thin and unsubstantiated.”
More recently, prosecutors made an unannounced visit to a construction site at the Fed’s headquarters but were turned away, drawing a rebuke from a defense attorney in the case who called the maneuver “not appropriate.”Warsh said during the Senate hearing Tuesday that he never promised the White House that he would cut interest rates, even as the president renewed his calls for the central bank to do so.
“The president never once asked me to commit to any particular interest rate decision, period,” Kevin Warsh, a former top Fed official, said under questioning by the Senate Banking Committee. “Nor would I ever agree to do so if he had. … I will be an independent actor if confirmed as chair of the Federal Reserve.”
Warsh’s comments came just hours after Trump, in an interview on CNBC, was asked if he would be disappointed if Warsh didn’t immediately cut rates and responded, “I would.”
The decision to abandon the investigation represents a rare pullback for a Justice Department that over the last year has moved aggressively, albeit unsuccessfully, to prosecute public figures the president does not like.
Robert Hur, an attorney for the Federal Reserve Board of Governors, didn’t immediately respond Friday to an email seeking comment.
Business
Firefly Aerospace: Future Looks More Certain Than Before (NASDAQ:FLY)
I write about stocks I’m personally interested in adding to my portfolio. I’m not a professional advisor, but I study business and economics and analyze markets full-time. My writing is meant for both complete beginners — I avoid unnecessary complexity — and advanced readers, as I always aim to offer a distinct and well-reasoned perspective.I also run a YouTube Channel called “The Market Monkeys” and break some of the stocks there as well.
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Business
FDA fast-tracks psychedelic drug research following Trump order
FILE PHOTO: Psilocybin or “magic mushrooms” are seen in an undated photo provided by the U.S. Drug Enforcement Agency in Washington, May 7, 2019.
DEA | Reuters
The U.S. Food and Drug Administration on Friday announced a series of measures aimed at accelerating the development of psychedelic treatments for serious mental illness.
That comes after President Donald Trump signed an executive order on Saturday directing federal health agencies to expand access to emerging therapies.
The move marks a significant shift toward supporting psychedelic-based medicines for conditions such as treatment-resistant depression, post-traumatic stress disorder and other substance use disorders, the FDA said.
“Under President Trump’s leadership, we are accelerating the research, approval and responsible access to promising mental health treatments,” Robert F. Kennedy Jr., secretary of the U.S. Department of Health and Human Services, said in the release. “The FDA will prioritize therapies with Breakthrough Therapy designation, where early evidence shows meaningful improvement.”
As part of the announcement, the FDA said it would issue national priority vouchers to companies studying psilocybin for depression and methylone for PTSD.
The agency also cleared an early-stage clinical trial for noribogaine hydrochloride, a derivative of ibogaine, as a potential treatment for alcohol use disorder. This is the first time a compound like it has been authorized for study in the U.S. and for human trial.
“These medications have the potential to address the nation’s mental health crisis,” FDA Commissioner Marty Makary said in the announcement. “It is critical that their development is grounded in sound science and rigorous clinical evidence.”
The FDA said allowing these studies to proceed does not mean the drugs are approved or proven safe and effective. Officials said data with be closely monitored as research advances.
“If they are approved, they will be approved with certain conditions. These are not the medications you get a prescription for and pick up at a pharmacy,” Makary told CNBC.
Makary went on to say decisions on some of these therapies could come as soon as this summer or fall.
The fast turnaround time for drug approvals has been a priority for the Trump administration, which dropped the decades-old standard of requiring two clinical trials for standard drug reviews earlier this year. The new policies have come with some criticism, as industry experts have warned about potential issues with a faster timetable.
With Friday’s psychedelic announcement, the Trump administration also said pricing remains an important consideration in fast-tracking trials.
“We have very openly said that affordability is an important part of a medication’s effectiveness on a population level,” Makary said. “Lowering drug prices is one of the top priorities in this administration, and it’s something we think about in every decision, including how we prioritize the vouchers.”
The announcement also follows the Trump administration saying it would ease restrictions on state-licensed medical cannabis operators.
Business
Primis Financial Corp. (FRST) Q1 2026 Earnings Call Transcript
Operator
Ladies and gentlemen, thank you for standing by. My name is Colby, and I’ll be your conference operator today. At this time, I would like to welcome you to the Primis Financial Corp. First Quarter Earnings Call. [Operator Instructions]
I will now turn the call over to Matthew Switzer. You may begin.
Matthew Switzer
Executive VP & CFO
Good morning, and thank you for joining us for Primis Financial Corp.’s 2026 First Quarter Webcast and Conference Call.
Before we begin, please note that many of our comments during this call will be forward-looking statements, which involve risk and uncertainty. There are many factors that could cause actual results to differ materially from the anticipated results or other expectations expressed in the forward-looking statements.
Further discussion of the company’s risk factors and other important information regarding our forward-looking statements are part of our recent filings with the Securities and Exchange Commission, including our recently filed earnings release, which has also been posted to the Investor Relations section of our corporate site, primisbank.com. We undertake no obligation to update or revise forward-looking statements to reflect changes in assumptions, the occurrence of unanticipated events or changes to future operating results over time.
In addition, some of the financial measures that we may discuss this morning are non-GAAP financial measures. How a non-GAAP measure relates to the most comparable GAAP measure will be discussed when the non-GAAP measures used, if not readily apparent.
I
Business
How Much Should Companies Spend on Branded Gifts?
This is a question that tends to induce bouts of anxiety and even fierce debate between different departments within the business. Without question, branded gifts have a value beyond their actual cost and they are a great way of getting your brand in front of people, but how much should you spend to achieve this aim?
It’s not easy to give a definitive answer about how much to spend on branded gifts. This is because every business will have a different size of budget in mind, and even a different mindset about what represents good value for money.
Certain branded gifts, such as mugs with logo, are often cost-effective solutions as you won’t have to spend huge sums of your marketing budget to see a positive return on your investment. To get a bit of clarity on the subject, here’s some key points to consider.
Understand why you are spending the money
A good starting point would be to appreciate why you are spending money on branded gifts and what you want to achieve from your investment in this proven marketing tool.
Ultimately, you are looking to try and build strong relationships with your customers and keep your name in their mindset when they are making purchasing decisions. Corporate gifts are a great way of achieving those aims as they help encourage a sense of loyalty and appreciation.
When you give someone a branded gift it helps them to feel valued. Even a relatively modest outlay on something like branded mugs or pens can really help strengthen that bond. How do you quantify that sort of response to your gift?
Instead of looking at the pure cost of a branded gift that you are going to use to promote your business it’s wise to also make an allowance for the benefits it delivers as well.
Finding the right balance
There can often be a fine dividing line between spending too much on corporate gifting, or too little. Neither scenario is good, for many reasons.
If you try to cut corners and end up with something that looks too cheap, it sends out the wrong message about your business and the recipient won’t feel that valued either. On the other hand, if your gift is too extravagant, it can lead someone to think that you must be making too much money out of them to be able to afford to spend so lavishly.
As you can see, it’s a fine balancing act to get it just right. A good approach would be to look at branded gifts that are of a good quality but also serve a useful or practical purpose, which makes them more likely to be well received.
A good example of this would be if you gave someone a good quality branded coffee mug. They are likely to use it on a regular basis, so you get a positive brand association, and it won’t have blown a huge hole in your overall marketing budget.
All things considered, rather than simply focusing on price to decide how much you spend you should also consider how well your branded gift will be received by the person you give it to.
Business
Earnings call transcript: First Western Financial beats Q1 2026 EPS estimates

Earnings call transcript: First Western Financial beats Q1 2026 EPS estimates
Business
The Procter & Gamble Company (PG) Q3 2026 Earnings Call Transcript
Conference Call Participants
Stephen Robert Powers – Deutsche Bank AG, Research Division
Dara Mohsenian – Morgan Stanley, Research Division
Lauren Lieberman – Barclays Bank PLC, Research Division
Peter Grom – UBS Investment Bank, Research Division
Peter Galbo – BofA Securities, Research Division
Christopher Carey – Wells Fargo Securities, LLC, Research Division
Robert Ottenstein – Evercore ISI Institutional Equities, Research Division
Kevin Grundy – BNP Paribas, Research Division
Filippo Falorni – Citigroup Inc., Research Division
Bonnie Herzog – Goldman Sachs Group, Inc., Research Division
Kaumil Gajrawala – Jefferies LLC, Research Division
Andrea Teixeira – JPMorgan Chase & Co, Research Division
Olivia Tong Cheang – Raymond James & Associates, Inc., Research Division
Robert Moskow – TD Cowen, Research Division
Edward Lewis – Rothschild & Co Redburn, Research Division
Michael Lavery – Piper Sandler & Co., Research Division
Presentation
Operator
Good morning, and welcome to Procter & Gamble’s quarter end conference call. Today’s event is being recorded for replay. This discussion will include a number of forward-looking statements.
If you will refer to P&G’s most recent 10-K, 10-Q and 8-K reports, you will see a discussion of factors that could cause the company’s actual results to differ materially from these projections.
As required by Regulation G, Procter & Gamble needs to make you aware that during the discussion, the company will make a number of references to non-GAAP and other financial measures. Procter & Gamble believes these measures provide investors with useful perspective on underlying business trends and has posted on its Investor Relations website, www.pginvestor.com, a full reconciliation of non-GAAP financial measures.
Now I will turn the call over to P&G’s Chief Financial Officer, Andre Schulten.
Andre Schulten
Chief Financial Officer
Good morning, everyone. Joining me on the call today are John Chevalier
Business
Island's inflation rate is 2.7%, new figures show
Statistics Jersey says there have been “sharp increases” in some energy prices.
Business
AI Dominance Fuels Strong Buy Consensus Despite High Valuation
SANTA CLARA, Calif. — Nvidia Corp. remains one of the most compelling yet polarizing investment stories in 2026, with Wall Street analysts overwhelmingly recommending investors buy shares of the AI chip leader even as the stock trades at elevated valuations following massive gains driven by insatiable demand for its GPUs.

AFP
As of late April 2026, Nvidia’s consensus rating stands as Strong Buy from dozens of analysts covering the stock. The average 12-month price target hovers around $268–$275, implying roughly 30–35% upside from recent trading levels near $200. Individual targets range from conservative lows near $210 to optimistic highs of $380, reflecting varying assumptions about the pace of AI infrastructure spending.
The bull case is straightforward and powerful. Nvidia continues to dominate the artificial intelligence accelerator market with its Blackwell and Hopper architectures. Data Center revenue has exploded, powering massive hyperscale buildouts by companies like Microsoft, Google, Meta and Amazon. Recent quarterly results showed revenue exceeding $68 billion in one period, with gross margins remaining exceptionally strong above 70%. Analysts project continued robust growth through 2027 as inference workloads and enterprise AI adoption accelerate.
CEO Jensen Huang has repeatedly emphasized that the company is still in the early innings of the AI revolution. New product cycles, including the Rubin architecture expected later in 2026, keep Nvidia firmly ahead of competitors. Partnerships, software moats through CUDA, and expanding total addressable market in robotics, autonomous vehicles and sovereign AI initiatives provide multiple growth vectors.
Several major banks and research firms have raised price targets in recent months. Rosenblatt, JPMorgan, Bank of America and others see significant upside, with some calling for $300+ by year-end. The consensus among more than 50 analysts shows overwhelming Buy or Strong Buy ratings, with very few Holds and almost no Sells.
Bears, however, highlight legitimate risks. Nvidia’s valuation — trading at premium forward multiples — leaves little room for disappointment. Competition from AMD, custom chips from hyperscalers, and potential margin pressure as the market matures could weigh on returns. Geopolitical tensions, export restrictions to China and any slowdown in Big Tech capital expenditure represent meaningful headwinds. Some analysts caution that expectations may already be too high.
For long-term growth investors, the case for buying Nvidia remains compelling. The company sits at the center of the most transformative technology shift since the internet. Strong balance sheet, exceptional execution under Huang, and a widening technological lead support continued outperformance. Many portfolio managers view it as a core holding for exposure to AI infrastructure.
Shorter-term traders or more conservative investors might exercise caution at current levels. Pullbacks on any perceived AI spending moderation could offer better entry points. Diversification is essential given the stock’s volatility and concentration risk in a single technology theme.
Institutional ownership remains very high, and retail enthusiasm continues. Options activity shows bullish sentiment overall, though elevated implied volatility reflects uncertainty around upcoming product cycles and macro factors. The stock has delivered extraordinary returns over the past several years, but past performance does not guarantee future results.
Nvidia’s trajectory in 2026 will likely be shaped by successful execution on next-generation platforms, sustained data center demand and the company’s ability to defend its massive market share. Positive developments on these fronts could drive shares significantly higher, while any stumbles might lead to sharp corrections typical of high-growth tech names.
Ultimately, whether to buy or sell Nvidia in 2026 depends heavily on individual risk tolerance, time horizon and conviction in the AI secular trend. Growth-oriented investors with a multi-year perspective generally see it as a Buy. Those seeking stability or concerned about valuations may prefer to Hold existing positions or wait for dips. Most advisors recommend sizing positions thoughtfully within a diversified portfolio.
As the AI supercycle continues unfolding, Nvidia stands as the clearest and most dominant beneficiary. With strong analyst support, robust fundamentals and multiple growth drivers, the company offers significant potential for patient investors — even after years of spectacular gains. The debate is not whether Nvidia will grow, but how much and at what valuation the market is willing to pay.
-
Fashion7 days agoWeekend Open Thread: Theodora Dress
-
Business5 days agoPowerball Result April 18, 2026: No Jackpot Winner in Powerball Draw: $75 Million Rolls Over
-
Politics7 days agoPalestine barred from entering Canada for FIFA Congress
-
Entertainment5 days ago
NBA Analyst Charles Barkley Chimes in on Ice Spice McDonald’s Fiasco
-
Tech6 days agoAuto Enthusiast Scores Running Tesla Model 3 for Two Grand and Turns It Into Bare-Bones Go-Kart
-
Politics5 days agoZack Polanski demands ‘council homes not luxury flats for foreign investors’
-
Crypto World7 days agoRussia Pushes Bill to Criminalize Unregistered Crypto Services
-
Politics4 days agoGary Stevenson delivers timely reminder to register to vote as deadline TODAY
-
Business2 days agoRolls-Royce Voted UK’s Most Iconic Trade Mark as IPO Register Hits 150
-
Politics2 days agoDisabled people challenge government SEND proposals over segregation concerns
-
Politics2 days agoMaking troops accountable for war crimes threatens US alliance, ex-SAS colonel warns
-
Crypto World7 days agoRussia Introduces Bill To Criminalize Unregistered Crypto Services
-
Politics2 days agoStarmer handler McSweeney to be dragged from shadows by Foreign Affairs Committee
-
Politics2 days ago
Wings Over Scotland | How To Get Away With Crimes
-
Politics2 days agoZack Polanski responds to home secretary’s taser threat
-
Crypto World6 days agoKelp DAO rsETH Bridge Hack Drains $292M as DeFi Losses Top $600M in Two Weeks
-
Politics2 days ago‘Iran is still a nuclear threat’
-
News Videos7 days agoAP Politics, Buggana Analyzes Reasons For Financial Instability Due To Amaravati
-
Crypto World3 days agoNew York sues Coinbase, Gemini over prediction market offerings
-
Business2 days agoThe Job Benefits Most Men Don’t Know to Negotiate

You must be logged in to post a comment Login